Does read as though the approval covers the sales to 'professional or self test use' 'but I don't know enough about the regulatory structure of the NZ medical device approvals market. TBH I wasn't even aware we made an application to the TGA equivalent in NZ lol.
Though, reading over the announcement of the AccessBio renegotiated supply agreement it does indicate that AT1 has a right to only sell the POC (professional use) RAT in Aus and NZ. This right is not extended to the sales of the 10million self-use tests in the NZ market. See below
- Forums
- ASX - By Stock
- AT1
- Ann: Atomo receives approval for its COVID-19 antigen test in NZ
Ann: Atomo receives approval for its COVID-19 antigen test in NZ, page-5
-
- There are more pages in this discussion • 10 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add AT1 (ASX) to my watchlist
(20min delay)
|
|||||
Last
2.0¢ |
Change
0.001(2.63%) |
Mkt cap ! $12.14M |
Open | High | Low | Value | Volume |
2.0¢ | 2.0¢ | 2.0¢ | $98 | 5K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
7 | 777274 | 1.9¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
2.0¢ | 431397 | 5 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
7 | 777274 | 0.019 |
5 | 656664 | 0.018 |
1 | 60000 | 0.016 |
3 | 366662 | 0.015 |
1 | 36000 | 0.014 |
Price($) | Vol. | No. |
---|---|---|
0.020 | 431397 | 5 |
0.021 | 32000 | 1 |
0.022 | 40000 | 1 |
0.024 | 126743 | 3 |
0.025 | 459000 | 2 |
Last trade - 14.53pm 18/09/2024 (20 minute delay) ? |
Featured News
AT1 (ASX) Chart |